GENE-16. EVALUATING THE UTILITY OF INTEGRATED CLINICAL SEQUENCING FOR CHILDHOOD NEURO-ONCOLOGY PATIENTS: THE TEXAS KIDSCANSEQ STUDY

Benzer Materyaller

• PATH-29. HIGH FREQUENCY OF CLINICALLY-RELEVANT TUMOR VARIANTS DETECTED BY MOLECULAR TESTING OF HIGH-RISK PEDIATRIC CNS TUMORS – PRELIMINARY FINDINGS FROM THE TEXAS KidsCanSeq STUDY
  Yazar:: Lin, Frank Y, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• GENE-09. MUTATION SIGNATURE ANALYSIS IN AN ULTRAHYPERMUTATED MEDULLOBLASTOMA PREDICTS UNDERLYING GERMLINE POLYMERASE PROOFREADING DEFICIENCY IN A CHILD WITH CLINICAL FEATURES OF CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
  Yazar:: Lindsay, Holly, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• ASSESSING THE UTILITY OF CLINICAL TUMOR SEQUENCING IN THE PEDIATRIC NEURO-ONCOLOGY CLINIC
  Yazar:: Parsons, D. Williams, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• TBIO-20. CLINICAL TUMOR WHOLE EXOME SEQUENCING FOR PEDIATRIC NEURO-ONCOLOGY PATIENTS – RESULTS FROM THE BAYLOR ADVANCING SEQUENCING IN CHILDHOOD CANCER CARE (BASIC3) CLINICAL SEQUENCING STUDY
  Yazar:: Lin, Frank, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• GE-06 IDENTIFICATION OF TARGETABLE MUTATIONS IN RARE PEDIATRIC BRAIN TUMORS BY CLINICAL WHOLE EXOME SEQUENCING
  Yazar:: Lin, Frank Y., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)